Main navigation
AstraZeneca is an innovation-driven, integrated, global pharmaceutical company. Our mission is to make the most meaningful difference to patient health through great medicines, and to create enduring value for our shareholders and society through industry-leading R&D productivity, commercial excellence and operational efficiency.
Our strategy centres on four main priorities: strengthen the pipeline, grow the business, re-shape the business and promote a culture of responsibility and accountability. These priorities are described below, together with details of our objectives; the measures we use to assess our progress; the initiatives in place to drive achievement of our objectives; and a summary of our 2008 performance.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 20-Nov-2009 23:29 GMT
Detailed share priceStock symbol - AZN
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
